Monitoring HIV tropism and Maraviroc regimens in clinical routine – 48 weeks of follow-up data

P. Braun, E. Wolf, S. Scholten, W. Köthemann, A. Trein, A. Neuwirth, E. Schnaitmann, F. Wiesmann, R. Ehret, C. Höhn, H. Jäger & H. Knechten
Background: Prior to initiating therapy with Maraviroc, the knowledge of the patients' viral tropism is crucial. The focus of this evaluation (11/2007–01/2010) was to prove the practicability of HIV tropism prediction and consequently therapeutical success of Maraviroc regimens[for full text, please go to the a.m. URL]